Protective Actions of PPAR-γ Activation in Renal Endothelium

Protective Actions of PPAR-γ Activation in Renal Endothelium

Renal endothelial damage is pivotal in the initiation and progression of renal disease. Damaged renal endothelium may be regenerated through proliferation of local endothelium and circulation-derived endothelial progenitor cells. Activation of the PPAR-γ-receptors present on endothelial cells affec...

Full description

Saved in:

Bibliographic Details
Main Authors:	Peter E. Westerweel, Marianne C. Verhaar
Format:	Article
Language:	English
Published:	Wiley 2008-01-01
Series:	PPAR Research
Online Access:	http://dx.doi.org/10.1155/2008/635680
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Role of PPARs in the Endothelium: Implications for Cancer Therapy
by: David Bishop-Bailey, et al.
Published: (2008-01-01)

Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases
by: Ajit A. Kulkarni, et al.
Published: (2012-01-01)

To Live or to Die: Prosurvival Activity of PPARγ in Cancers
by: Y. Lynn Wang, et al.
Published: (2008-01-01)

PPARγ and PPARδ as Modulators of Neoplasia and Cell Fate
by: Robert I. Glazer, et al.
Published: (2008-01-01)

PPARγ in Inflammatory Bowel Disease
by: Vito Annese, et al.
Published: (2012-01-01)

Protective Effect of PPARγ Agonists on Cerebellar Tissues Oxidative Damage in Hypothyroid Rats
by: Yousef Baghcheghi, et al.
Published: (2016-01-01)

The PPARγ Agonist Rosiglitazone Is Antifibrotic for Scleroderma Lung Fibroblasts: Mechanisms of Action and Differential Racial Effects
by: Galina S. Bogatkevich, et al.
Published: (2012-01-01)

Structural Features and Transcriptional Activity of Chicken PPARs (α, β, and γ)
by: Ichiro Takada, et al.
Published: (2013-01-01)

Therapeutic Implications of PPARγ in Human Osteosarcoma
by: Eric R. Wagner, et al.
Published: (2010-01-01)

PPARγ in Bacterial Infections: A Friend or Foe?
by: Aravind T. Reddy, et al.
Published: (2016-01-01)

PPARγ and Its Role in Cardiovascular Diseases
by: Mini Chandra, et al.
Published: (2017-01-01)

Therapeutic Implications of PPARγ in Cardiovascular Diseases
by: Hiroshi Hasegawa, et al.
Published: (2010-01-01)

Thiazolidinediones on PPARγ: The Roles in Bone Remodeling
by: Wei Wei, et al.
Published: (2011-01-01)

Resolving the Two “Bony” Faces of PPAR-γ
by: Beata Lecka-Czernik, et al.
Published: (2006-01-01)

The Model of PPARγ-Downregulated Signaling in Psoriasis
by: Vladimir Sobolev, et al.
Published: (2020-01-01)

Selective Modulators of PPAR-γ Activity: Molecular Aspects Related to Obesity and Side-Effects
by: Fang Zhang, et al.
Published: (2007-01-01)

Fine-Tuning Reception in the Bone: PPARγ and Company
by: Z. Elizabeth Floyd, et al.
Published: (2006-01-01)

The Modulation of PPARγ1 and PPARγ2 mRNA Expression by Ciglitazone in CD3/CD28-Activated Naïve and Memory CD4+ T Cells
by: Mohd Nor Norazmi, et al.
Published: (2012-01-01)

Piperine Alleviates Doxorubicin-Induced Cardiotoxicity via Activating PPAR-γ in Mice
by: Jie Yan, et al.
Published: (2019-01-01)

Activation of PPARγ Protects Obese Mice from Acute Lung Injury by Inhibiting Endoplasmic Reticulum Stress and Promoting Mitochondrial Biogenesis
by: Yin Tang, et al.
Published: (2022-01-01)

PPARγ as a Novel Therapeutic Target in Lung Cancer
by: Aravind T. Reddy, et al.
Published: (2016-01-01)

The Role of PPARγ in the Transcriptional Control by Agonists and Antagonists
by: Tamotsu Tsukahara
Published: (2012-01-01)

PPAR-γ Signaling Crosstalk in Mesenchymal Stem Cells
by: Ichiro Takada, et al.
Published: (2010-01-01)

PPARγ and Its Agonists in Chronic Kidney Disease
by: Yuhua Ma, et al.
Published: (2020-01-01)

PPAR-γ Agonists and Their Role in Primary Cicatricial Alopecia
by: Sarawin Harnchoowong, et al.
Published: (2017-01-01)

Identification of Bexarotene as a PPARγ Antagonist with HDX
by: David P. Marciano, et al.
Published: (2015-01-01)

PPARγ Agonist Rosiglitazone Suppresses Renal mPGES-1/PGE2 Pathway in db/db Mice
by: Ying Sun, et al.
Published: (2013-01-01)

α-amanitin induces hepatotoxicity via PPAR-γ inhibition and NLRP3 inflammasome activation
by: Haowei Wang, et al.
Published: (2025-01-01)

PPARγ and the Innate Immune System Mediate the Resolution of Inflammation
by: Amanda Croasdell, et al.
Published: (2015-01-01)

Review of the Structural and Dynamic Mechanisms of PPARγ Partial Agonism
by: Alice J. Kroker, et al.
Published: (2015-01-01)

Solution Structures of PPARγ2/RXRα Complexes
by: Judit Osz, et al.
Published: (2012-01-01)

New Insights into the PPARγ Agonists for the Treatment of Diabetic Nephropathy
by: Zhanjun Jia, et al.
Published: (2014-01-01)

The Role of PPARγ in Helicobacter pylori Infection and Gastric Carcinogenesis
by: Jong-Min Lee, et al.
Published: (2012-01-01)

Homocysteine and Hypertension in Diabetes: Does PPARγ Have a Regulatory Role?
by: Utpal Sen, et al.
Published: (2010-01-01)

Expression of GPR43 in Brown Adipogenesis Is Enhanced by Rosiglitazone and Controlled by PPARγ/RXR Heterodimerization
by: Jiamiao Hu, et al.
Published: (2018-01-01)

Intracardiac Fibrinolysis and Endothelium Activation Related to Atrial Fibrillation Ablation with Different Techniques
by: Orsolya Hajas, et al.
Published: (2020-01-01)

Anticancer Role of PPARγ Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes
by: P. J. Simpson-Haidaris, et al.
Published: (2010-01-01)

The Role of the PAX8/PPARγ Fusion Oncogene in Thyroid Cancer
by: Kimberly A. Placzkowski, et al.
Published: (2008-01-01)

A Role for PPARγ in the Regulation of Cytokines in Immune Cells and Cancer
by: Xiao Yi Yang, et al.
Published: (2008-01-01)

Regulation of Glial Cell Functions by PPAR-𝜸 Natural and Synthetic Agonists
by: Antonietta Bernardo, et al.
Published: (2008-01-01)